← Back to Search

Videoconferencing Smoking Cessation Program for Smoking

N/A

Recruiting

Led By Stephanie L Marhefka, PhD

Research Sponsored by University of South Florida

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up study day 360

Awards & highlights

Study Summary

This trial is testing whether a smoking cessation program delivered over videoconferencing is more effective than a control program for people with certain chronic conditions.

Who is the study for?

The Positively Quit Trial is for adults over 18 living in the US with certain chronic conditions who smoke cigarettes and are motivated to quit. Participants must have internet access, be able to use Zoom, speak English, and not be pregnant or breastfeeding. They cannot be using other tobacco treatments.Check my eligibility

What is being tested?

This study tests a smoking cessation program delivered via videoconferencing against an Attention Matched Control condition that doesn't focus on quitting but has equal contact hours. Both groups get nicotine patches and advice to quit across 12 sessions.See study design

What are the potential side effects?

Possible side effects may include those associated with nicotine replacement therapy such as skin irritation from patches, dizziness, racing heartbeat, sleep problems or unusual dreams.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ study day 360

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~study day 360

This trial's timeline: 3 weeks for screening, Varies for treatment, and study day 360 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Biochemically confirmed 30-day point prevalence abstinence (BC30ppa) day 360

Biochemically confirmed 7-day point prevalence abstinence (BC7ppa) day 360

Biochemically confirmed sustained abstinence (BC.SA) day 360

Secondary outcome measures

Biochemically confirmed 30-day point prevalence abstinence (BC30ppa) day 180

Biochemically confirmed 30-day point prevalence abstinence (BC30ppa) days 90

Biochemically confirmed 7-day point prevalence abstinence (BC7ppa) day 180

+5 more

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Positively MeExperimental Treatment1 Intervention

Positively Me is a 12-session (8 [1.5] hour main sessions plus four booster sessions) intervention guided by Social Cognitive Theory to promote smoking cessation in people with certain health conditions.

Group II: Positively LivingPlacebo Group1 Intervention

Positively Living is a modified updated version of a healthy living intervention based on Social Cognitive Theory that is designed for people with certain health conditions and attention-matched to the experimental condition (8 [1.5] hour main sessions plus four booster sessions).

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of South FloridaLead Sponsor

411 Previous Clinical Trials

186,547 Total Patients Enrolled

National Cancer Institute (NCI)NIH

13,663 Previous Clinical Trials

40,925,423 Total Patients Enrolled

Stephanie L Marhefka, PhDPrincipal InvestigatorUniversity of South Florida College of Nursing

Media Library

Positively Living Clinical Trial Eligibility Overview. Trial Name: NCT04449458 — N/A

Smoking/Cigarette Smoking Research Study Groups: Positively Living, Positively Me

Smoking/Cigarette Smoking Clinical Trial 2023: Positively Living Highlights & Side Effects. Trial Name: NCT04449458 — N/A

Positively Living 2023 Treatment Timeline for Medical Study. Trial Name: NCT04449458 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many subjects have signed up to participate in this clinical research?

"Affirmative, the clinicaltrials.gov website confirms that this medical trial is actively seeking volunteers. The initial launch was on June 10th 2020 and it has recently been updated on August 8th 2022. This study requires 482 participants at two different sites of research."

Answered by AI

Are there any current enrollment opportunities for this research?

"Affirmative. Clinicaltrials.gov attests that patient recruitment for this research study, which was initially posted on June 10th 2020, is currently in progress. 482 participants are needed from 2 trial locations."

Answered by AI

What is the principal motivation behind this investigation?

"This clinical study's primary objective is to established biochemical confirmed sustained abstinence (BC.SA) on day 360, while secondary goals comprise of assessing self-efficacy for abstaining from smoking on day 90 via the Smoking: Self-Efficacy/Temptation Short Form (Velicor et al., 1990), biochemically confirming 7 and 30 days point prevalence abstinence respectively on days 42 and 90 using cotinine swab tests with levels less than 10ng/ml indicating successful adherence."

Answered by AI